Literature DB >> 8442752

Impaired antioxidant status in diabetic rat liver. Effect of vanadate.

A K Saxena1, P Srivastava, R K Kale, N Z Baquer.   

Abstract

In vivo effects of vanadate on the antioxidant status of control and alloxan diabetic rats liver were examined. The increased oxidative stress during diabetes caused a decline in the activities of glutathione peroxidase (GPx), catalase (CAT), CuZn superoxide dismutase (CuZn-SOD) and Mn-superoxide dismutase (Mn-SOD) in the liver. Reduced glutathione (GSH) was also depleted, but the level of oxidized glutathione and glutathione reductase activity remained unchanged in the livers of diabetic rats. Vanadate treatment of diabetic rats (0.6 mg/mL in drinking water) resulted in almost complete restoration of GPx and Mn-SOD but caused only a partial restoration of CuZn-SOD. However, CAT and GSH were found to be lowered further in vanadate-treated diabetic rats as compared to untreated diabetic rat. Similar decreases in CAT and GSH levels were also observed in the vanadate-treated controls. These results suggest that vanadate, an insulin-mimetic agent, effectively normalized hyperglycemia, but unlike insulin, could not completely restore the altered endogenous defence mechanisms in diabetic liver.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8442752     DOI: 10.1016/0006-2952(93)90124-f

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  33 in total

1.  Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.

Authors:  I E León; J F Cadavid-Vargas; I Tiscornia; V Porro; S Castelli; P Katkar; A Desideri; M Bollati-Fogolin; S B Etcheverry
Journal:  J Biol Inorg Chem       Date:  2015-09-24       Impact factor: 3.358

2.  Regulation and control of glucose overutilization in erythrocytes by vanadate.

Authors:  N Z Baquer; A K Saxena; P Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

3.  Endurance training and glutathione-dependent antioxidant defense mechanism in heart of the diabetic rats.

Authors:  Mustafa Gül; Mustafa Atalay; Osmo Hänninen
Journal:  J Sports Sci Med       Date:  2003-06-01       Impact factor: 2.988

Review 4.  Vanadium in Biosphere and Its Role in Biological Processes.

Authors:  Deepika Tripathi; Veena Mani; Ravi Prakash Pal
Journal:  Biol Trace Elem Res       Date:  2018-03-09       Impact factor: 3.738

5.  Efficacy of lower doses of vanadium in restoring altered glucose metabolism and antioxidant status in diabetic rat lenses.

Authors:  Anju Preet; Bihari L Gupta; Pramod K Yadava; Najma Z Baquer
Journal:  J Biosci       Date:  2005-03       Impact factor: 1.826

6.  Study on total antioxidant status in relation to oxidative stress in type 2 diabetes mellitus.

Authors:  A Jamuna Rani; S V Mythili
Journal:  J Clin Diagn Res       Date:  2014-03-15

7.  Oral administration of orthovanadate and Trigonella foenum graecum seed power restore the activities of mitochondrial enzymes in tissues of alloxan-induced diabetic rats.

Authors:  Shalini Thakran; Najma Z Baquer
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

8.  The plant extracts of Momordica charantia and Trigonella foenum-graecum have anti-oxidant and anti-hyperglycemic properties for cardiac tissue during diabetes mellitus.

Authors:  Uma Nath Tripathi; Deepak Chandra
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

9.  Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.

Authors:  I E Leon; V Porro; A L Di Virgilio; L G Naso; P A M Williams; M Bollati-Fogolín; S B Etcheverry
Journal:  J Biol Inorg Chem       Date:  2014-01       Impact factor: 3.358

10.  Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.

Authors:  Bayani Uttara; Ajay V Singh; Paolo Zamboni; R T Mahajan
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.